Cargando…
Suppression of angiogenesis and tumor growth in vitro and in vivo using an anti-angiopoietin-2 single-chain antibody
Hepatocellular carcinomas (HCCs) are tumors with a highly developed vascular architecture. HCC cells require access to blood vessels for growth and metastasis; therefore, the inhibition of angiogenesis represents a potential therapeutic target for HCC that may reduce the mortality and morbidity from...
Autores principales: | ZHANG, ZHONG-LIN, ZHANG, JI-FA, YUAN, YU-FENG, HE, YUE-MING, LIU, QUAN-YAN, MAO, XIAO-WEN, AI, YONG-BIAO, LIU, ZHI-SU |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919851/ https://www.ncbi.nlm.nih.gov/pubmed/24520243 http://dx.doi.org/10.3892/etm.2014.1476 |
Ejemplares similares
-
Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo
por: Han, Jing, et al.
Publicado: (2018) -
Glycation of Tie-2 Inhibits Angiopoietin-1 Signaling Activation and Angiopoietin-1-Induced Angiogenesis
por: Zhou, Haiyan, et al.
Publicado: (2022) -
Plasma angiopoietin-2 is persistently elevated after non-small cell lung cancer surgery and stimulates angiogenesis in vitro
por: Zhou, Leng, et al.
Publicado: (2016) -
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer
por: Carbone, Carmine, et al.
Publicado: (2018) -
A novel peptide specifically binding to VEGF receptor suppresses angiogenesis in vitro and in vivo
por: Zhang, Yuan, et al.
Publicado: (2017)